Yasutaka Takeda

Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy

Ryoichi Bessho, Yumi Takiyama, Takao Takiyama et al. · Scientific Reports · 2019 · 156 citations · Full text

Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice

Yasutaka Takeda, Yukihiro Fujita, Jun Honjo et al. · Diabetologia · 2011 · 119 citations · Full text

Insulin Signaling, Biochemistry, Medicine +9

Loss of HIF-1α impairs GLUT4 translocation and glucose uptake by the skeletal muscle cells

Hidemitsu Sakagami, Yuichi Makino, Katsutoshi Mizumoto et al. · American Journal of Physiology-Endocrinology and Metabolism · 2014 · 64 citations

Skeletal Muscle Cells, Metabolic Remodeling, Glucose Uptake +18

Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects

Tsuyoshi Yanagimachi, Yukihiro Fujita, Yasutaka Takeda et al. · Molecular Metabolism · 2017 · 37 citations · Full text

LIPID CONCENTRATION AND COMPOSITION IN HUMAN FETAL TISSUE DURING DEVELOPMENT

Jacques F. Roux, Yasutaka Takeda, Ani Grigorian · PEDIATRICS · 1971 · 29 citations

Lipid Analysis, Nutrition, Fetal Medicine +16